20 May 2013
Keywords: celltech, sells, rest, lonza, bio, uk, biotechnology
Article | 08 January 1998
UK biotechnology company Celltech has received L10.5 million ($17.2million) from Alusuisse-Lonza of Switzerland as payment for the sale of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 May 1998
© 2013 thepharmaletter.com